LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
5.60
0.00 (0.00%)
At close: Jun 8, 2026, 4:00 PM EDT
5.61
+0.01 (0.18%)
After-hours: Jun 8, 2026, 4:10 PM EDT
LENSAR Market Cap
LENSAR has a market cap or net worth of $67.78 million as of June 8, 2026. Its market cap has decreased by -58.88% in one year.
Market Cap
67.78M
Enterprise Value
56.86M
1-Year Change
-58.88%
Ranking
Category
Stock Price
$5.60
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has decreased from $78.01M to $67.78M, a decrease of -13.10%. That is a compound annual growth rate of -2.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 67.78M | -51.20% |
| Dec 31, 2025 | 138.92M | 33.78% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapid Micro Biosystems | 98.35M |
| Neuronetics | 89.77M |
| Sera Prognostics | 89.67M |
| Outset Medical | 84.90M |
| electroCore | 72.34M |
| Pulmonx | 64.62M |
| Xtant Medical Holdings | 63.86M |
| Spectral AI | 60.15M |